Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD)

Código QR

Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD)

Yifang Li, Yanzhen Chen, Xing Tian, Shanshan Zhang, Jian Jiao Department of Gastroenterolgy & Hepatology, China-Japan Union Hospital, Jilin University, Changchun, 130033, People’s Republic of ChinaCorrespondence: Jian JiaoDepartment of Gastroenterology & Hepatology, China-J...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Li Y, Chen Y, Tian X, Zhang S, Jiao J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	obese non-obese non-alcoholic liver disease gender characteristic Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/b3de97bbf0444e6ebed9076b1189abb6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Obesity and nonalcoholic fatty liver disease: current perspectives
por: Sarwar R, et al.
Publicado: (2018)

Inadequate identification of fatty liver disease, obesity, and metabolic syndrome by family physicians
por: Mahamid M, et al.
Publicado: (2018)

Relationship between nonalcoholic fatty liver disease and bone mineral density in adolescents with obesity: a meta-analysis
por: Sun Y, et al.
Publicado: (2019)

Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C
por: Pegah Golabi, et al.
Publicado: (2022)

Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease
por: Szanto KB, et al.
Publicado: (2019)

Plasma concentrations of zonulin are elevated in obese men with fatty liver disease
por: Kim AS, et al.
Publicado: (2018)

Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress
por: Sue Shea, et al.
Publicado: (2021)

The Impact of Vitamin D in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Patients with Morbid Obesity
por: Borges-Canha M, et al.
Publicado: (2021)

Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry
por: Alswat K, et al.
Publicado: (2021)

DHA Protects Against Hepatic Steatosis by Activating Sirt1 in a High Fat Diet-Induced Nonalcoholic Fatty Liver Disease Mouse Model
por: Luo X, et al.
Publicado: (2020)

The negative and detrimental effects of high fructose on the liver, with special reference to metabolic disorders
por: Mai BH, et al.
Publicado: (2019)

Association of salivary C-reactive protein with the obesity measures and markers in children
por: Selvaraju V, et al.
Publicado: (2019)

High-Normal Serum Thyrotropin Levels Increased the Risk of Non-Alcoholic Fatty Liver Disease in Euthyroid Subjects with Type 2 Diabetes
por: Tan Y, et al.
Publicado: (2021)

The Association Between Different Obesity Phenotypes and Liver Fibrosis Scores in Elderly Individuals with Fatty Liver in Taiwan
por: Lee YS, et al.
Publicado: (2021)

Obesity and morbid obesity associated with higher odds of hypoalbuminemia in adults without liver disease or renal failure
por: Mosli RH, et al.
Publicado: (2017)

Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease
por: Shida T, et al.
Publicado: (2019)

A Non-Invasive Prediction Model for Non-Alcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Based on the Population of Northern Urumqi, China
por: Xue M, et al.
Publicado: (2021)

Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease
por: Chen L, et al.
Publicado: (2020)

Obesity and brain illness: from cognitive and psychological evidences to obesity paradox
por: Monda V, et al.
Publicado: (2017)

Obesity and the development of type 2 diabetes: the effects of fatty tissue inflammation
por: Schuster D
Publicado: (2010)

Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease
por: Liang XY, et al.
Publicado: (2021)

Effect of albumin on indicators of systemic inflammation and endothelial dysfunction in patients with alcoholic liver cirrhosis in combination with obesity
por: N.H. Virstiuk, et al.
Publicado: (2020)

Common and Unique Factors and the Bidirectional Relationship Between Chronic Kidney Disease and Nonalcoholic Fatty Liver in Type 2 Diabetes Patients
por: Lee YJ, et al.
Publicado: (2020)

Serum ZAG and Adiponectin Levels Were Closely Related to Obesity and the Metabolically Abnormal Phenotype in Chinese Population
por: Liu M, et al.
Publicado: (2020)

Salidroside-Mitigated Inflammatory Injury of Hepatocytes with Non-Alcoholic Fatty Liver Disease via Inhibition TRPM2 Ion Channel Activation
por: Feng Q, et al.
Publicado: (2019)

Cytoprotective and suicidal signaling in oxidative stress
por: Videla,Luis A
Publicado: (2010)

Contribution of Different Phenotypes of Obesity to Metabolic Abnormalities from a Cross-Sectional Study in the Northwest China
por: Lu X, et al.
Publicado: (2021)

The Interplay of Vitamin D Deficiency and Cellular Senescence in The Pathogenesis of Obesity-Related Co-Morbidities
por: Abdulhadi Bima, et al.
Publicado: (2021)

Association Between Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome with Gallstone Disease, South Iran: A Population-Based Study
por: Sepehrimanesh M, et al.
Publicado: (2020)

Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
por: Daniela Maria Tanase, et al.
Publicado: (2021)

MRI assessment of ectopic fat accumulation in pancreas, liver and skeletal muscle in patients with obesity, overweight and normal BMI in correlation with the presence of central obesity and metabolic syndrome
por: Pieńkowska J, et al.
Publicado: (2019)

Comprehensive comparison of MetAP2 tissue and cellular expression pattern in lean and obese rodents
por: Han J, et al.
Publicado: (2018)

Association of Overweight, Obesity and Abdominal Obesity with Socioeconomic Status and Educational Level in Colombia
por: Jimenez-Mora MA, et al.
Publicado: (2020)

Body Mass Index and Indicators of Lipid Exchange in Liver Steatosis of Alcoholic and Nonalcoholic Genesis in Residents of Rural Area: Similarities and Differences
por: N. V. Mikhaylova, et al.
Publicado: (2019)

Association Between Different Obesity Patterns and the Risk of Developing Type 2 Diabetes Mellitus Among Adults in Eastern China: A Cross-Sectional Study
por: Lu Y, et al.
Publicado: (2021)

Plasma cholinesterase is associated with Chinese adolescent overweight or obesity and metabolic syndrome prediction
por: Han Y, et al.
Publicado: (2019)

Glucocorticoid-Induced Fatty Liver Disease
por: Rahimi L, et al.
Publicado: (2020)

Obesity: outcome of standardized life-style change in a rehabilitation clinic. An observational study
por: Haslacher H, et al.
Publicado: (2019)

The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010–2011
por: Khang AR, et al.
Publicado: (2019)

Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndrome
por: Aleksandr I. Pavlov, et al.
Publicado: (2021)